Journal
CYTOMETRY
Volume 47, Issue 1, Pages 66-71Publisher
WILEY-LISS
DOI: 10.1002/cyto.10037
Keywords
-
Categories
Funding
- NATIONAL CANCER INSTITUTE [R01CA077618] Funding Source: NIH RePORTER
- NCI NIH HHS [R01 CA77618] Funding Source: Medline
Ask authors/readers for more resources
Pharmacogenomics is a fast-growing field of investigations that aims to further elucidate the inherited nature of interindividual differences in drug disposition and effects, with the ultimate goal of providing a stronger scientific basis for selecting the optimal drug therapy. Providing the right drug for the right patient is an important problem in the treatment of cancer. This is mainly due to the lack of information about the sensitivity of the tumor for a specific treatment modality, such as either chemotherapy or radiation treatment. This presentation highlights two approaches to identify responsiveness to treatment. Both approaches are based on the identification of expression profiles. The first approach concentrates on drug resistance and the second on the signaling pathways leading up to the death of the cell. Both approaches provide expression profiles; however, the more dynamic expression profiling as used to determine the signaling in damage cells promises to be,I better determinant for the pharmacogenomic changes in expression profiles and, consequently, a potential better determinant for drug efficacy. Cytometry 47:66-71, 2002. (C) 2001 Wiley-Liss, Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available